# Certara Announces CFO Transition
Canonical URL: https://biopharmsignal.com/news/CERT/certara-announces-cfo-transition
Ticker: CERT
Company: Certara
Source: Certara
Published: 2026-06-25 13:46 EST
Original Source URL: https://ir.certara.com
## Summary

Reaffirms 2026 Guidance RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has notified the Company of his intent to resign from his office effective as of the end

## Article Body
Reaffirms 2026 Guidance RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has notified the Company of his intent to resign from his office effective as of the end
## Recent Company News
- 2026-06-25 13:46 EST — [Certara Announces CFO Transition](https://biopharmsignal.com/news/CERT/certara-announces-cfo-transition) — Source: Certara
- 2026-06-25 13:46 EST — [Certara Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/CERT/certara-reports-first-quarter-2026-financial-results) — Source: Certara
- 2026-06-25 13:46 EST — [Certara Automates Scientific Workflows with Phoenix® Cloud](https://biopharmsignal.com/news/CERT/certara-automates-scientific-workflows-with-phoenixr-cloud) — Source: Certara
- 2026-06-25 13:46 EST — [Certara Reports Third Quarter 2025 Financial Results](https://biopharmsignal.com/news/CERT/certara-reports-third-quarter-2025-financial-results) — Source: Certara
- 2026-06-25 13:46 EST — [Certara Appoints Jon Resnick as Chief Executive Officer](https://biopharmsignal.com/news/CERT/certara-appoints-jon-resnick-as-chief-executive-officer) — Source: Certara
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)